[ad_1]
![[BrightInsight in MedCity News] How digital health impacts the development and adoption of cancer immunotherapies](https://blog.ourcrowd.com/wp-content/uploads/2018/02/medcity-news-logo.png){kind=logo}
In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.
Read more here.
[ad_2]
Source link
[BrightInsight in MedCity News] How digital health impacts the development and adoption of cancer immunotherapies
Related Posts
Leave a Reply
LATEST STORIES
Own and operated by The Ike Lemuwa Group, LLC a Commonwealth of Virginia Limited Liability Company, USA.
Info@nigeriasmartnews.com / info@ikelemuwagroup.com
Toll-Free: 1 888 642 8433
3821 Dominion Drive Dumfries, Virginia, 22026. USA